Sign inSign up
Wed 20 May 2026
Disrupting a $120B Market: Exclusive Investor Interview with Nadav Cohen
Fennec Medical is pioneering the future of orthopedic surgery with its AI-powered surgical co-pilot designed to make joint replacement procedures safer, smarter, and more predictable.

"The GILC is absolutely great. My experience is fantastic. Traditional fundraising is tough. It's a lot of cold calls and dealings with gatekeepers and so on... WithGILC, it cuts through the noise. They put me face to face with the active investors and really, it's just absolutely fantastic." - Nadav Cohen  

 

Led by CEO & Co-founder Nadav Cohen, the company is transforming one of the most challenging aspects of hip replacement surgery by helping surgeons prevent intraoperative fractures in real time.

 

In this exclusive interview with the Global Investment Leaders Club, Nadav Cohen shares how Fennec’s innovative EchoSTEM technology combines advanced sensors, AI, and real-time data analysis to support surgeons during procedures and improve patient outcomes.
Powered by a world-class team of surgeons, engineers, physicists, and AI experts, Fennec Medical is building technology that could become a critical layer in the future of robotic-assisted surgery.

 

The Global Investment Leaders Club continues connecting innovative companies like Fennec Medical with active global investors, helping breakthrough technologies gain visibility and strategic support worldwide.

Participants mentioned in the article
Nadav
Nadav Cohen PhD
CEO & Co-founder
Fennec Medical
Articles correlated to current collection
Healthcare
title
John Evans
Beyond the Pain: How Tracie Reclaimed Her Life with Accufix
For decades, Tracie’s life was defined by motion. As a health coach, personal trainer, and fitness coordinator at the YMCA, she identified as inseparable from her physical vitality.
5 mid read | 26 days ago
Healthcare
title
Brendan Emery
The Data Gap at the Heart of Animal Health
A new biosensing platform is challenging one of veterinary medicine's oldest limitations — the absence of continuous biological data between clinical visits.
12 mid read | about 1 month ago
Healthcare
title
Jean-Marie Saint-Remy
A New Hope in Cancer Treatment: How Equaly is Breaking Down Tumor Defenses
Equaly is developing a breakthrough immunotherapy that empowers the body’s own immune system to combat the most challenging cancers.
6 mid read | about 1 month ago
Healthcare
title
Wim Van den Broek
The ENZYSYSTEM Breakthrough: Transforming Blood Clotting Care with Portable, Light-Based Technology
A breakthrough in biotechnology is set to change this paradigm: ENZYSYSTEM has unveiled a transformative platform called TGAlum, a microfluidic technology that promises to do for blood clotting what the glucose monitor did for diabetes management.
8 mid read | about 1 month ago
See more recommendations
G.I.L.C. Monthly Chronicles
Receive a monthly delivery of exclusive articles, industry-specific insights and viewpoints from global investors. All tailored to help you make informed investment decisions.
Subscribe now
Join the community
Establish and expand trustful relationships with investment leaders in all regions of the world.
Explore unlimited investment opportunities, get access to first hand information,markets and capital. Enjoy the most effective high-end investment networking on Gilc.Club.
Join now
© 2023